Skopos Labs, Inc. Bio N Tech Se Transaction History
Skopos Labs, Inc.
- $300 Million
- Q3 2024
A detailed history of Skopos Labs, Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, Skopos Labs, Inc. holds 91 shares of BNTX stock, worth $10,353. This represents 0.0% of its overall portfolio holdings.
Number of Shares
91Holding current value
$10,353% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BNTX
# of Institutions
357Shares Held
38.3MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$945 Million0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$514 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$496 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$216 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$206 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27.6B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...